Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care London, are investigating ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also stave off dementia?

A new study from UCLA Health has uncovered how inflammation in brain blood vessels exacerbates damage in vascular dementia ...

Remarkable new findings about the sugar stores in neurons have unlocked an entire new method of treating Alzheimer's disease ...

Researchers at the Francis Crick Institute and UCL have shown that genetic messages are misplaced in nerve cells in a model ...

In a nutshell People with type 2 diabetes taking semaglutide (Ozempic/Wegovy) showed up to 46% lower dementia risk compared ...

The study, carried out by experts from the University of Nottingham and funded by the National Institute for Health Research ...

The UK's National Institute for Health and Care Excellence (NICE) has declined to recommend two new Alzheimer's drugs for routine NHS use in England. While disappointing for some families affected by ...

A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could ...

These tests can help sort out vascular dementia from other types of dementia and Alzheimer disease. Lumbar puncture (Spinal tap). This is done to analyze cerebrospinal fluid for inflammation, ...

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...